text stringlengths 1 17.8k |
|---|
8.3 Requirements for Security/ Post-Test Administration 8.3.1 The Sample Collection Authority shall define criteria ensuring that each Sample collected is stored in a manner that protects its integrity, identity and security prior to transport from the Doping Control Station . |
At a minimum, these criteria should include detailing and documenting t he location where Samples are stored and who has custody of the Samples and/or is permitted access to the Samples. |
The DCO shall ensure that any Sample is stored in accordance with these criteria. |
8.3.2 The Sample Collection Authority shall develop a system for recording the Chain of Custody of the Samples and Sample collection documentation to ensure that the documentation for each Sample is completed and securely handled. |
This shall include confirming that both the Samples and Sample collection documentation have arrived at their intended destinations . |
The Laboratory shall report any irregularities to the Testing Authority on the condition of Samples upon arrival in line with the International Standard for Laboratories . |
8.3.3 The Sample Collection Authority shall develop a system to ensure that, where required, instructions for the type of analysis to be conducted are provided to the Laboratory that will be conducting the analysis. |
In addition, the Anti -Doping Organization shall provide the Laboratory with information as required under Article 7.4.5 c), f), i), k), l), m), q), r), w), aa), bb) and cc) for result reporting and statistical purposes and include whether Sample retention in accordance with Article 4.7.3. is required. |
[Comment to 8.3: Information as to how a Sample is stored prior to departure from the Doping Control Station may be recorded on, for example, a DCO report. |
The type of analysis for the Laboratory may be recorded on a Chain of Custody form. |
ADOs can refer to the WADA website for a DCO report and/or Chain of Custody form template.] |
ISTI – Effective 1 January 2023 Page 54 of 92 9.0 Transport of Samples and Documentation 9.1 Objective a) To ensure that Samples and related documentation arrive at the Laboratory that will be conducting the analysis in proper condition to do the necessary analysis; and b) To ensure the Sample Collection Session documentation is sent by the DCO to the Testing Authority in a secure and timely manner. |
9.2 General 9.2.1 Transport starts when the Samples and related documentation leave the Doping Control Station and ends with the confirmed receipt of the Samples and Sample Collection Session documentation at their intended destinations. |
9.2.2 The main activities are arranging fo r the secure transport of Samples and related documentation to the Laboratory that will be conducting the analysis and arranging for the secure transport of the Sample Collection Session documentation to the Testing Authority . |
9.3 Requirements for T ransport and Storage of Samples and Documentation 9.3.1 The Sample Collection Authority shall authorize a transport system that ensures Samples and documentation are transported in a manner that protects their integrity, identity and security. |
9.3.2 Samples shall always be transported to the Laboratory that will be analyzing the Samples using the Sample Collection Authority’s authorized transport method, as soon as possible after the completion of the Sample Collection Session. |
Samples shall be transported in a manner which minimizes the potential for Sample degradation due to factors such as time delays and extreme temperature variations. |
[Comment to 9.3.2: Anti -Doping Organizations should discuss transportation requirements for particular missions (e.g., where the Sample has been collected in less than hygienic conditions, or where delays may occur in transporting the Samples to the Laboratory ) with the Laboratory that will be analyzing the Samples, to establish what is necessary in the particular c ircumstances of such mission (e.g., refrigeration or freezing of the Samples).] |
9.3.3 Documentation identifying the Athlete shall not be included with the Samples or documentation sent to the Laboratory that will be analyzing the Samples . |
9.3.4 The DCO shall send all relevant Sample Collection Session documentation to the Sample Collection Authority , using the Sample Collection Authority’s authorized transport method (which may include electronic transmission), as soon as practicable after the completion of the Sample Collection Session. |
9.3.5 If the Samples with accompanying documentation or the Sample Collection Session documentation are not received at their respective intended destinations, or if a Sample’ s integrity , identity or security may have been com promised during transport, ISTI – Effective 1 January 2023 Page 55 of 92 the Sample Collection Authority shall check the Chain of Custody , and the Testing Authority shall consider whether the Samples should be voided. |
9.3.6 Documentation related to a Sample Collection Session and/or an anti -doping rule violation shall be stored by the Testing Authority and/or the Sample Collection Authority for the period and other requirements specified in the International Standard for the Protection of Privacy and Personal Information. |
[Com ment to 9.3: While the requirements for transport and storage of Samples and documentation herein apply equally to all urine , blood , blood Athlete Biological Passport and dried blood spot Samples, additional requirements for standard blood can be found in Annex D - Collection of Venous Blood Samples , additional requirements for the transportation of Blood Samples for the Athlete Biological Passport can be found in Annex I - Collection, Sto rage and Transport of B lood Athlete Biological Passport Samples , and additional requirements for the transportation of dried blood spot Samples can be found in Annex J - Collection, Storage and Transport of Dried Blood Spot Samples .] |
10.0 Ownership of Samples 10.1 Samples collected from an Athlete are owned by the Testing Authority for the Sample Collection Session in question. |
10.2 The Testing Authority may transfer ownership of the Samples to the Results Management Authority or to another Anti-Doping Organization upon request. |
10.3 WADA may assume Testing Authority in certain circumstances in accordance with the Code and the International Standard for Laboratories . |
10.4 Where the Testing Authority is not the Passport Custodian, the Testing Authority that initiated and directed the Sample collection maintains the responsibility for additional Analytical Testing of the Sample. |
This includes the performance of further Confirmation Procedure(s) upon requests generated automatically by the Adaptive Model of the Athlete Biological Passport in ADAMS (e.g., GC/C/IRMS triggered by elevated T/E) or a request by the APMU (e.g., GC/C/ IRMS requested due to abnormal secondary Markers of the urinary “longitudinal steroi d profile ” or e rythropoietin receptor agonists (ERAs) analysis tests due to suspicious hematological Marker values ). |
ISTI – Effective 1 January 2023 Page 56 of 92 PART THREE: STANDARDS FOR INTELLIGENCE GATHERING AND INVESTIGATIONS 11.0 Gathering, Assessment and U se of I ntelligence 11.1 Objective Anti-Doping Organizations shall ensure they are able to obtain, assess and process anti -doping intelligence from all available sources, to help deter and detect doping, to inform the development of an effective, intelligent and proportionate Test Distribut ion Plan, to plan Target Testing, and to conduct investigations as required by Code Article 5.7. |
The objective of Article 11 is to establish standards for the efficient and effective gathering, assessment and processing of such intelligence for these purposes . |
[Comment to 11.1: While Testing will always remain an integral part of the anti -doping effort, Testing alone is not sufficient to detect and establish to the requisite standard all of the anti -doping rule violations identified in the Code. |
In particular, while Use of Prohibited Substances and Prohibited Methods may often be uncovered by analysis of Samples, the other Code anti -doping rule violations (and, often, Use) can usually only be effectively identified and pursued through the gathering and investigation of ‘non-analytical’ anti-doping intelligence and information. |
This means that Anti -Doping Organizations need t o develop efficient and effective intelligence- gathering and investigation functions. |
WADA has devised Intelligence and Investigations Guidelines with case studies to assist Anti-Doping Organizations to better understand the types of ‘non- analytical’ intelligence that may be available and to provide support and guidance to Signatories in their efforts to comply with the Code and the International Standards. ] |
11.2 Gathering of A nti-Doping Intelligence 11.2.1 Anti-Doping Organizations shall do everything in their power to ensure that they are able to capture or receive anti -doping intelligence from all available sources, including, but not limited to, Athletes and Athlete Support Personnel (including Substantial Assistance provided pur suant to Code Article 10.7.1) and members of the public (e.g., by means of a confidential telephone hotline), Sample Collection Personnel (whether via mission reports, incident reports, or otherwise), Laboratories , pharmaceutical companies, other Anti-Doping Organizations , WADA , National Federations, law enforcement, other regulatory and disciplinary bodies, and the media (in all its forms). |
11.2.2 Anti-Doping Organizations shall have policies and procedures in place to ensure that anti-doping intelligence captured or received is handled securely and confidentially, that sources of intelligence are protected, that the risk of leaks or inadvertent disclosure is properly addressed, and that intelligence shared with them by law enforcement, other relevant authorities and/or other third parties, is processed, used and disclosed only for legitimate anti -doping purposes. |
11.3 Assessment and Analysis of Anti-Doping Intelligence 11.3.1 Anti-Doping Organizations shall ensure that they are able to assess all anti -doping intelligence upon receipt for relevance, reliability and accuracy, taking into account the nature of the source and the circumstances in which the intelligence has been captured or received. |
ISTI – Effective 1 January 2023 Page 57 of 92 [Comment to 11.3.1: There are various models that may be used as the basis for the assessment and analysis of anti -doping intelligence. |
There are also databases and case management systems that may be used to assist in the organization, processing, analysis and cross -referencing of such intelligence.] |
11.3.2 All anti- doping intelligence captured or received by an Anti -Doping Organization should be collated and analy zed to establish patterns, trends and relationships that may assist the Anti-Doping Organization in developing an effective anti -doping strategy and/or in determining (where the i ntelligence relates to a particular case) whether there is reasonable cause to suspect that an anti -doping rule violation may have been committed, such that further investigation is warranted in accordance with Article 12 and the International Standard for Results Management . |
11.4 Intelligence Outcomes 11.4.1 Anti-doping intelligence shall be used to assist for the following purposes (without limitation): developing, reviewing and revising the Test Distribution Plan and/or determining when to conduct Target Testing, in each case in accordance with Article 4 and/or to create targeted intelligence files to be referred for investigation in accordance with Article 12 . |
11.4.2 Anti-Doping Organizations should also develop and implement policies and procedures for the sharing of intelligence (where appropriate, and subject to applicable law) with other Anti-Doping Organizations (e.g., if the intelligence relates to Athletes or other Persons under their authority) and/or law enforcement and/or other relevant regulatory or disciplinary authorit ies (e.g., if the intelligence suggests the possible commission of a crime or regulatory offence or breach of other rules of conduct). |
11.4.3 Anti-Doping Organizations should develop and implement policies and procedures to facilitate and encourage confidential s ources as outlined within WADA’s Confidential Source P olicy available on WADA’s website. |
12.0 Investigations 12.1 Objective The objective of Article 12 is to establish standards for the efficient and effective conduct of investigations that Anti -Doping Organizations must implement under the Code, including but not limited to: a) The investigation of Atypical Findings , Atypical Passport Findings and Adverse Passport Findings , in accordance with the International Standard for Results Management; b) The investigation of any other analytical or non -analytical information and/or intelligence where there is reasonable cause to suspect that an anti -doping rule violation may have been committed, in accordance with the International Standard for Results Management ; c) The investigation of the circumstances surrounding and/or arising from an Adverse Analytical Finding to gain further intelligence on other Persons or methods involved in doping (e.g., interviewing the relevant Athlete); and ISTI – Effective 1 January 2023 Page 58 of 92 d) Where an anti-doping rule violation by an Athlete is established, the investigation into whether Athlete Support Personnel or other Persons may have been involved in that violation, in accordance with Code Article 20. |
12.1.1 In each case, the purpose of the investigation is to achieve one of the following either: a) to rule out the possible violation/involvement in a violation; b) to develop evidence t hat supports the initiation of an anti -doping rule violation proceeding in accordance with Code Article 8; or c) to provide evidence of a breach of the Code or applicable International Standard. |
12.2 Investigating Possible Anti-doping Rule Violations 12.2.1 Anti-Doping Organizations shall ensure that they are able to investigate confidentially and effectively any analytical or non- analytical information or intelligence that indicates there is reasonable cause to suspect that an anti -doping rule violation may have been committed, in accordance with the International Standard for Results Management . |
[Comment to 12.2.1: Where an attempt to collect a Sample from an Athlete produces information indicating a possible evasion of Sample collection and/or refusal or failure to submit to Sample collection after due notification, in violation of Code Article 2.3, or possible Tampering or Attempted Tampering with Doping Control, in violation of Code Article 2.5, the matter shall be investigated in accordance with the Int ernational Standard for Results Management.] |
12.2.2 The Anti-Doping Organization shall gather and record all relevant information and documentation as soon as possible, in order to develop that information and documentation into admissible and reliable evidence i n relation to the possible anti -doping rule violation, and/or to identify further lines of enquiry that may lead to the discovery of such evidence. |
The Anti -Doping Organization shall ensure that investigations are conducted fairly, objectively and impartially at all times. |
The conduct of investigations, the evaluation of information and evidence identified in the course of that investigation, and the outcome of the investigation, shall be fully documented. |
[Comment to 12.2.2: It is important that information is provided to and gathered by the investigating Anti -Doping Organization as quickly as possible and in as much detail as possible because the longer the period between the incident and investigation, the greater the risk that certain evidence may no longer exist. |
Investigations should not be conducted with a closed mind, pursuing only one outcome (e.g., institution of anti -doping rule violation proceedings against an Athlete or other Person). |
Rather, the investigator(s) should be open to and should consider all possible outcomes at each key stage of the investigation, and should seek to gather not only any available evidence indicating that there is a case to answer but also any available evidence indicating that there is no case to answer.] |
12.2.3 The Anti-Doping Organization should make use of all investigative resources reasonably available to it to conduct its investigation. |
This may include obtaining ISTI – Effective 1 January 2023 Page 59 of 92 information and assistance from law enforcement and other relevant authorities, including other regulators. |
However, the Anti-Doping Organization should also make full use of all investigative resources at its own disposal, including the Athlete Biological Passport program, investigative powers conferred under applicable rules (e.g., the power to demand the production of relevant documents and information, and the power to interview both potential witnesses and the Athlete or other Person who is the subject of the investigation), and the power to suspend a period of Ineligibility imposed on an Athlete or other Person in return for the provision of Substantial Assistance in accordance with Code Article 10.7.1. |
12.2.4 Athletes and Athlete Support Personnel are required under Code Article 21 to cooperate with investigations conducted by Anti -Doping Organizations . |
If they fail to do so, disciplinary action should be taken against them under applicable rules. |
If their conduct amounts to subversion of the investigation process (e.g., by providing false, misleading or incomplete information, and/or by destroying potenti al evidence), the Anti-Doping Organization should bring proceedings against them for violation of Code Article 2.5 ( Tampering or Attempted Tampering). |
12.3 Investigation Outcomes 12.3.1 The Anti-Doping Organization shall come to a decision efficiently and without undue delay as to whether proceedings should be brought against the Athlete or other Person asserting commission of an anti -doping rule violation. |
As set out in Code Article 13.3, if an Anti-Doping Organiza tion fails to make such decision within a reasonable deadline set by WADA , WADA may elect to appeal directly to CAS as if the Anti-Doping Organization had rendered a decision finding that no anti -doping rule violation has been committed. |
As noted in the co mment to Code Article 13.3, however, before taking such action WADA will consult with the Anti -Doping Organization and give it an opportunity to explain why it has not yet rendered a decision. |
12.3.2 Where the Anti-Doping Organization concludes based on the resul ts of its investigation that proceedings should be brought against the Athlete or other Person asserting commission of an anti -doping rule violation, it shall give notice of that decision in the manner set out in the International Standard for Results Management and shall bring forward the proceedings against the Athlete or other Person in question in accordance with Code Article 8. |
12.3.3 Where the Anti-Doping Organization concludes, based on the results of its investigation, that proceedings should not be brought forward against the Athlete or other Person asserting commission of an anti -doping rule violation: 12.3.3.1 It shall notify WADA and the Athlete’s or other Person’s International Federation and National Anti -Doping Organization in writing of that decision, with reasons, in accordance with Code Article 14.1.4. |
12.3.3.2 It shall provide such other information about the investigation as is reasonably required by WADA and/or the International Federation and/or National Anti -Doping Organizati on in order to determine whether to appeal against that decision. |
ISTI – Effective 1 January 2023 Page 60 of 92 12.3.3.3 In any event, it shall consider whether any of the intelligence obtained and/or lessons learned during the investigation should be used to inform the development of its Test Distribution Plan and/or to plan Target Testing, and/or should be shared with any other body in accordance with Article 11.4.2. |
ISTI – Effective 1 January 2023 Page 61 of 92 ANNEX A - MODIFICATIONS FOR ATHLETES WITH IMPAIRMENTS A.1. |
Objective To ensure , where possible, that the particular needs of Athletes with impairments are considered in relation to the provision of a Sample without compromising the integrity of the Sample Collection Session. |
A.2. |
Scope Determining whether modifications are necessary starts with identification of situations where Sample collection involves Athletes with impairments and ends with modifications to Sample collection procedures and equipment where necessary and where possible. |
A.3. |
Responsibility A.3.1 The Testing Authority or Sample Collection Authority (as applicable) has responsibility for ensuring, when possible, that the DCO has any information and Sample Collection Equipment necessary to conduct a Sample Collection Session with an Athlete with an impairment, including details of such impairment that may affect the procedure to be followed in conducting a Sample Collection Session. |
A.3.2 The DCO has responsibility for Sample collection. |
A.4. |
Requirements A.4.1. |
All aspects of notification and Sample collection for Athletes with impairments shall be carried out in accordance with the standard notification and Sample collection procedures unless modifications are necessary due to the Athlete ’s impairment. |
[Comment to A.4.1: The Testing Authority in the case of an Athlete with an intellectual impairment, shall decide whether to obtain consent to Testing from their representative and inform the Sample Collection Authority and Sample Collection Personnel .] |
A.4.2. |
In planning or arranging Sample collection, the Sample Collection Authority and DCO shall consider whether there will be any Sample collection for Athletes with impairments that may require modifications to the standard procedures for notification or Sample collection, including Sample Collection Equipment and Doping Control Station. |
A.4.3. |
The Sample Collection Authority and DCO shall have the authority to make modifications as the situation requires when possible and as long as such modifications will not compromise the integrity, identity, and security of the Sample. |
The DCO shall consult the Athlete in order to determine what modifications may be necessary for the Athlete’s impairment. |
All such modifications shall be documented. |
A.4.4. |
An Athlete with an intellectual, physical or sensorial impairment may be assisted by the Athlete’s representative or Sample Collection Personnel during the Sample Collection Session where authorized by the Athlete and agreed to by the DCO . |
A.4.5. |
The DCO may decide that alternative Sample Collection Equipment or an alternati ve Doping Control Station will be used when required to enable the Athlete to provide the ISTI – Effective 1 January 2023 Page 62 of 92 Sample, as long as the Sample’ s integrity, identity and security will not be affected. |
A.4.6. |
Athletes who are using urine collection or drainage systems are required to eliminate existing urine from such systems before providing a urine Sample for analysis. |
Where possible, the existing urine collection or drainage system should be replaced with a new, unused catheter or drainage system prior to collection of the Sample . |
A.4.7. |
Should an Athlete require any additional equipment in order to be able to provide a Sample, including but not limited to catheters and drainage systems, it is the sole responsibility of th e Athlete to have the necessary equipment available for this purpose and understand how to use it. |
A.4.8. |
For Athletes with vis ion or intellectual impairments, the DCO and/or Athlete may determine if they shall have a representative present during the Sample Collection Session. |
During the Sample Collection Session, a representative of the Athlete and/or a representative of the DCO may observe the witnessing DCO /Chaperone while the Athlete is passing the urine Sample. |
This representative or these representatives may not directly observe the passing of the urine Sample, unless requested to do so by the Athlete. |
A.4.9. |
The DCO shall record modifications made to the standard Sample collection procedures for Athletes with impairments, including any applicable modifications specified in the above actions. |
ISTI – Effective 1 January 2023 Page 63 of 92 ANNEX B - MODIFICATIONS FOR ATHLETES WHO ARE MINORS B.1 Objective To ensure , where possible, that the particular needs of Athletes who are Minors are met in relation to the provision of a Sample , without compromising the integrity of the Sample Collection Session. |
B.2 Scope Determining whether modifications are necessary starts with identification of situations where Sample collection involves Athletes who are Minors and ends with modifications to Sample collection procedures where necessary and where possible. |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.